Quality Improvement Interventions to Improve Critical Congenital Heart Disease Screening

Lisa A Hom1, Clarissa Chan Salcedo2, Mary Revenis3

  • 1Children's National Heart Institute, Children's National Health System, Washington, DC.

Pediatric Quality & Safety
|November 21, 2019
PubMed

Insights

Newborn screening for critical congenital heart disease (CCHD) using pulse oximetry significantly reduced documentation errors and protocol violations. This quality improvement initiative improved screening accuracy and infant safety.

Area of Science:

  • Neonatal Health
  • Public Health Policy
  • Quality Improvement Science

Background:

  • Newborn screening for critical congenital heart disease (CCHD) via pulse oximetry enhances detection and lowers infant mortality.
  • The Healthy Hearts of Babies Act mandated CCHD screening for newborns in Washington D.C. starting in 2015.
  • Internal electronic health record analysis identified significant opportunities to improve CCHD screening documentation and protocol adherence.

Purpose of the Study:

  • To decrease CCHD screening documentation errors by 75%.
  • To reduce CCHD screening protocol violations by 75%.
  • To sustain these improvements for a minimum of six months.

Main Methods:

  • Implementation of CCHD screening in a large children's hospital's NICU starting February 2014.
  • An interdisciplinary team conducted regular report analysis, monthly feedback, and electronic health record refinements from January 2016 to December 2018.
  • Statistical process control charts were utilized to compare baseline data with the intervention period.

Main Results:

  • A total of 2,214 infants were screened for CCHD between February 2014 and December 2018.
  • Average documentation errors decreased from 23.5% (baseline) to 1.2% (intervention), sustained over two years.
  • Average protocol violations decreased from 2.1% (baseline) to 0.6% (intervention), demonstrating sustained improvement.

Conclusions:

  • A multimodal quality improvement project successfully reduced CCHD screening documentation errors.
  • The project also achieved a sustained reduction in CCHD screening protocol violations.
  • These findings highlight the effectiveness of systematic quality improvement in enhancing newborn screening processes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
198
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
287
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
934
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
218
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K